SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001493152-22-014492
Filing Date
2022-05-19
Accepted
2022-05-19 16:30:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 74017
  Complete submission text file 0001493152-22-014492.txt   75849
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88625 | Film No.: 22943422
SIC: 8071 Services-Medical Laboratories

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G